CRISPR Therapeutics CRSP announced that it has entered into a collaboration deal with San Diego-based privately held company, ...

The partnership with Sirius expands CRISPR Therapeutics’ modality toolkit, especially in the cardiovascular space.

CRISPR Therapeutics is paying $25 million upfront to work on multiple siRNA targets with Sirius Tx with an early focus on the ...

CRISPR Therapeutics and Sirius Therapeutics have formed a strategic ... clinical trials and pipeline products and programs, including, without limitation, expectations regarding data, safety ...

-Under the agreement, CRISPR Therapeutics will make an upfront payment of $25 million in cash and $70 million in equity to ...

SAN DIEGO & SHANGHAI, May 09, 2025--(BUSINESS WIRE)--Sirius Therapeutics ... clinical programs and expand our pipeline, to deliver "transformative siRNA therapeutics for patients with chronic ...